Company: CERO
Filing Date: 2025-06-06
Form Type: 424B3
Source: 0001213900-25-052185
Chunk: 7

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-06-06
Form: 424B3
Chunk 7
---
 the Company and certain Investors, mutually agreed to effect, and effected, an Additional Closing (as defined in the Securities
Purchase Agreement), with respect to 938 additional shares of Series D Preferred Stock for gross proceeds of approximately $750,400. The
rights, preferences and privileges of the Series D Preferred Stock are set forth in the certificate of designations of rights and preferences
of the Series D Preferred Stock (the “Certificate of Designations”), filed with the Secretary of State of the State of Delaware
on April 22, 2025. The offering and sale of the shares of Series D Preferred Stock were issued and, upon conversion of the Series D Preferred
Stock, the shares of Common Stock underlying the Series D Preferred Stock will be issued, in each case, without registration under the
Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”) as a transaction not involving a public offering and Rule 506 promulgated under the Securities Act as sales to accredited
investors, and in reliance on similar exemptions under applicable state laws.

The description of the terms and conditions of the
Securities Purchase Agreement and the Certificate of Designations do not purport to be complete and each is qualified in its entirety
by the full text of Securities Purchase Agreement and the Certificate of Designations, as applicable, which are filed as exhibits to the
Company’s Current Reports on Form 8-K filed on April 22, 2025 and on April 25, 2025, respectively.

| Item 8.01 | Other Events. |

The Company also issued a press release announcing
the additional closing on June 6, 2025, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K.

| Item 9.01 | Financial Statements and Exhibits. |

(d)

| Exhibit Number |     | Description                                                                                                                                                                                                                                                                      |
| 3.1†           |     | Certificate of Designation of Preferences, Rights and Limitations of the Series D Convertible Preferred Stock, dated April 22, 2025 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-40877) filed on April 25, 2025).         |
| 10.1†          |     | Securities Purchase Agreement, dated of April 21,